AAAAAA

   
Results: 1-8 |
Results: 8
PHARMACOKINETICS OF HUMAN RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR, ADMINISTERED INTRAABDOMINALLY, IN A RAT PERITONITIS MODEL
Authors: VANGOOR H BOM VJJ VANDERMEER J SLUITER WJ GEERARDS S VANDERSCHAAF W DEGRAAF JS BLEICHRODT RP
Citation: H. Vangoor et al., PHARMACOKINETICS OF HUMAN RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR, ADMINISTERED INTRAABDOMINALLY, IN A RAT PERITONITIS MODEL, European surgical research, 28(4), 1996, pp. 287-294
PLASMA-LEVELS OF PROTEIN-S, PROTEIN-C, AND FACTOR-X - EFFECTS OF SEX,HORMONAL STATE AND AGE
Authors: HENKENS CMA BOM VJJ VANDERSCHAAF W PELSMA PM SIBINGA CTS DEKAM PJ VANDERMEER J
Citation: Cma. Henkens et al., PLASMA-LEVELS OF PROTEIN-S, PROTEIN-C, AND FACTOR-X - EFFECTS OF SEX,HORMONAL STATE AND AGE, Thrombosis and haemostasis, 74(5), 1995, pp. 1271-1275
SENSITIVITY TO ACTIVATED PROTEIN-C (APC) RELATED WITH SEX, USE OF ORAL-CONTRACEPTIVES AND FACTOR-VIII LEVELS
Authors: HENKENS CMA VANDERMEER J VANDERSCHAAF W PELSMA PM GEERARDS S SEINEN A BOM VJJ
Citation: Cma. Henkens et al., SENSITIVITY TO ACTIVATED PROTEIN-C (APC) RELATED WITH SEX, USE OF ORAL-CONTRACEPTIVES AND FACTOR-VIII LEVELS, Thrombosis and haemostasis, 73(6), 1995, pp. 1120-1120
THE CLINICAL EXPRESSION OF HEREDITARY PROTEIN-C AND PROTEIN-S DEFICIENCY - A RELATION TO CLINICAL THROMBOTIC RISK-FACTORS AND TO LEVELS OF PROTEIN-C AND PROTEIN-S
Authors: HENKENS CMA VANDERMEER J HILLEGE JL VANDERSCHAAF W BOM VJJ HALIE MR
Citation: Cma. Henkens et al., THE CLINICAL EXPRESSION OF HEREDITARY PROTEIN-C AND PROTEIN-S DEFICIENCY - A RELATION TO CLINICAL THROMBOTIC RISK-FACTORS AND TO LEVELS OF PROTEIN-C AND PROTEIN-S, Blood coagulation & fibrinolysis, 4(4), 1993, pp. 555-562
RISK OF THROMBOEMBOLISM DURING PREGNANCY AND PUERPERIUM IN PROTEIN-C DEFICIENT WOMEN
Authors: HENKENS CMA HILLEGE HL VANDERSCHAAF W BOM VJJ VANDERMEER J
Citation: Cma. Henkens et al., RISK OF THROMBOEMBOLISM DURING PREGNANCY AND PUERPERIUM IN PROTEIN-C DEFICIENT WOMEN, Thrombosis and haemostasis, 69(6), 1993, pp. 713-713
INTRAABDOMINAL USE OF HUMAN TISSUE-TYPE PLASMINOGEN-ACTIVATOR IN A RAT PERITONITIS MODEL
Authors: BOM VJJ VANGOOR H GEERARDS S VANDERSCHAAF W VANDERMEER J BLEICHRODT RP
Citation: Vjj. Bom et al., INTRAABDOMINAL USE OF HUMAN TISSUE-TYPE PLASMINOGEN-ACTIVATOR IN A RAT PERITONITIS MODEL, Thrombosis and haemostasis, 69(6), 1993, pp. 828-828
RAPID ENZYME-IMMUNOASSAY OF ANTISTREPTOKINASE ANTIBODIES IN HUMAN PLASMA
Authors: BOM VJJ BRUGEMANN J VANDERSCHAAF W VANWIJK RT VANDERMEER J
Citation: Vjj. Bom et al., RAPID ENZYME-IMMUNOASSAY OF ANTISTREPTOKINASE ANTIBODIES IN HUMAN PLASMA, Clinica chimica acta, 218(2), 1993, pp. 121-129
ANTISTREPTOKINASE ANTIBODIES INHIBIT FIBRINOLYTIC EFFECTS OF ANISTREPLASE IN ACUTE MYOCARDIAL-INFARCTION
Authors: BRUGEMANN J VANDERMEER J BOM VJJ VANDERSCHAAF W DEGRAEFF PA LIE KI
Citation: J. Brugemann et al., ANTISTREPTOKINASE ANTIBODIES INHIBIT FIBRINOLYTIC EFFECTS OF ANISTREPLASE IN ACUTE MYOCARDIAL-INFARCTION, The American journal of cardiology, 72(5), 1993, pp. 462-464
Risultati: 1-8 |